Tumor-induced endothelial RhoA activation mediates tumor cell transendothelial migration and metastasis
Md Sanaullah Sajib,Fatema Tuz Zahra,Margarita Lamprou,Racheal Grace Akwii,Jee Hyun Park,Manuel Osorio,Paul Tullar,Colleen L Doci,Chonghe Zhang,Stephan Huveneers,Jaap D van Buul,Ming-Hai Wang,Maciej M Markiewski,Sanjay K Srivastava,Yi Zheng,J Silvio Gutkind,Junhao Hu,Ulrich Bickel,Dean Y Maeda,John A Zebala,Michail S Lionakis,Scott Trasti,Constantinos M Mikelis
DOI: https://doi.org/10.1101/2024.09.22.614304
2024-09-24
Abstract:The endothelial barrier plays an active role in transendothelial tumor cell migration during metastasis, however, the endothelial regulatory elements of this step remain obscure. Here we show that endothelial RhoA activation is a determining factor during this process. Breast tumor cell-induced endothelial RhoA activation is the combined outcome of paracrine IL-8-dependent and cell-to-cell contact β1 integrin-mediated mechanisms, with elements of this pathway correlating with clinical data. Endothelial-specific RhoA blockade or in vivo deficiency inhibited the transendothelial migration and metastatic potential of human breast tumor and three murine syngeneic tumor cell lines, similar to the pharmacological blockade of the downstream RhoA pathway. These findings highlight endothelial RhoA as a potent, universal target in the tumor microenvironment for anti-metastatic treatment of solid tumors.
Physiology